Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001567619-19-007515
Filing Date
2019-03-25
Accepted
2019-03-25 09:48:01
Documents
1
Effectiveness Date
2019-03-25
Items
Item 06c:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 9998
  Complete submission text file 0001567619-19-007515.txt   11176
Mailing Address 20 N. MERIDIAN STREET SUITE 801 INDIANAPOLIS IN 46204
Business Address 20 N. MERIDIAN STREET SUITE 801 INDIANAPOLIS IN 46204 317-684-9196
Apexian Pharmaceuticals, Inc. (Filer) CIK: 0001560913 (see all company filings)

EIN.: 450594393 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-335557 | Film No.: 19701521